These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 31016543)

  • 1. Targeting Cancer Via Resveratrol-Loaded Nanoparticles Administration: Focusing on In Vivo Evidence.
    Santos AC; Pereira I; Magalhães M; Pereira-Silva M; Caldas M; Ferreira L; Figueiras A; Ribeiro AJ; Veiga F
    AAPS J; 2019 Apr; 21(4):57. PubMed ID: 31016543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-time oral administration of resveratrol-loaded layer-by-layer nanoparticles to rats - a pharmacokinetics study.
    Santos AC; Veiga FJ; Sequeira JAD; Fortuna A; Falcão A; Pereira I; Pattekari P; Fontes-Ribeiro C; Ribeiro AJ
    Analyst; 2019 Mar; 144(6):2062-2079. PubMed ID: 30724915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol-loaded nanomedicines for cancer applications.
    Annaji M; Poudel I; Boddu SHS; Arnold RD; Tiwari AK; Babu RJ
    Cancer Rep (Hoboken); 2021 Jun; 4(3):e1353. PubMed ID: 33655717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology-based formulations for resveratrol delivery: Effects on resveratrol in vivo bioavailability and bioactivity.
    Santos AC; Pereira I; Pereira-Silva M; Ferreira L; Caldas M; Collado-González M; Magalhães M; Figueiras A; Ribeiro AJ; Veiga F
    Colloids Surf B Biointerfaces; 2019 Aug; 180():127-140. PubMed ID: 31035056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol-loaded polymeric nanoparticles suppress glucose metabolism and tumor growth in vitro and in vivo.
    Jung KH; Lee JH; Park JW; Quach CHT; Moon SH; Cho YS; Lee KH
    Int J Pharm; 2015 Jan; 478(1):251-257. PubMed ID: 25445992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zein nanoparticles as low-cost, safe, and effective carriers to improve the oral bioavailability of resveratrol.
    Nunes R; Baião A; Monteiro D; das Neves J; Sarmento B
    Drug Deliv Transl Res; 2020 Jun; 10(3):826-837. PubMed ID: 32207071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy.
    Wan S; Zhang L; Quan Y; Wei K
    R Soc Open Sci; 2018 Nov; 5(11):181457. PubMed ID: 30564426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Strategies in Resveratrol Delivery Systems.
    Machado ND; Fernández MA; Díaz DD
    Chempluschem; 2019 Jul; 84(7):951-973. PubMed ID: 31943987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLGA Nanoparticles and Their Versatile Role in Anticancer Drug Delivery.
    Khan I; Gothwal A; Sharma AK; Kesharwani P; Gupta L; Iyer AK; Gupta U
    Crit Rev Ther Drug Carrier Syst; 2016; 33(2):159-93. PubMed ID: 27651101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic Consequences of PLGA Nanoparticles in Docetaxel Drug Delivery.
    Rafiei P; Haddadi A
    Pharm Nanotechnol; 2017; 5(1):3-23. PubMed ID: 28948907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol loaded functionalized nanostructured lipid carriers for breast cancer targeting: Systematic development, characterization and pharmacokinetic evaluation.
    Poonia N; Kaur Narang J; Lather V; Beg S; Sharma T; Singh B; Pandita D
    Colloids Surf B Biointerfaces; 2019 Sep; 181():756-766. PubMed ID: 31234063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of novel conjugated resveratrol polymeric nanoparticles in reduction of plasma degradation, hepatic metabolism and its augmentation of anticancer activity in vitro and in vivo.
    Yee YJ; Benson HAE; Dass CR; Chen Y
    Int J Pharm; 2022 Mar; 615():121499. PubMed ID: 35065206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching from Conventional to Nano-natural Phytochemicals to Prevent and Treat Cancers: Special Emphasis on Resveratrol.
    Salman Ul Islam ; Ahmed MB; Mazhar Ul-Islam ; Shehzad A; Lee YS
    Curr Pharm Des; 2019; 25(34):3620-3632. PubMed ID: 31605574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonication-assisted Layer-by-Layer self-assembly nanoparticles for resveratrol delivery.
    Santos AC; Sequeira JAD; Pereira I; Cabral C; Collado Gonzallez M; Fontes-Ribeiro C; Ribeiro AJ; Lvov YM; Veiga FJ
    Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110022. PubMed ID: 31546400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Effect of Resveratrol-Loaded Solid Lipid Nanoparticles to Relieve Physical Fatigue for Sports Nutrition Supplements.
    Qin L; Lu T; Qin Y; He Y; Cui N; Du A; Sun J
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33202918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid functionalized nanoparticles as pharmaceutical carriers in drug delivery systems.
    Narmani A; Rezvani M; Farhood B; Darkhor P; Mohammadnejad J; Amini B; Refahi S; Abdi Goushbolagh N
    Drug Dev Res; 2019 Jun; 80(4):404-424. PubMed ID: 31140629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin- and resveratrol-co-loaded nanoparticles in synergistic treatment of hepatocellular carcinoma.
    Zheng Y; Jia R; Li J; Tian X; Qian Y
    J Nanobiotechnology; 2022 Jul; 20(1):339. PubMed ID: 35858935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.